fashion -WSS

fashion

author：Wikipedia 2025-09-30 17:59:33 - browse：221

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： CDC: Cases of alpha

hotspot

WSS

Study: Pain burden is higher in Black NFL players than white ones

Palantir health business leans on meeting customers’ needs

N.Y. state detects polio case, first in the U.S. since 2013

Oak trusses raised to roof of fire

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Biden announces an advanced cancer research initiative

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Walensky prepares to leave CDC — and Congress — behind

Ford recalls 870K F

Anesthesiologist group: stop taking Ozempic before surgery

An outrageous hospital charge: I paid $710 for an hour of babysitting

After affirmative action ruling, medical educators look to 'holistic review'

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Apple is now the first public company to be valued at $3 trillion

California’s proposed $25 per hour health care minimum wage

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

It's time to get medical device identifiers over the finish line

focus

NIH fellows want a pay raise. Will that mean less money for grants?

Public health communication lessons from Covid

Palantir health business leans on meeting customers’ needs

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

An outrageous hospital charge: I paid $710 for an hour of babysitting

Leqembi, other new Alzheimer’s drugs require better biomarkers

leisure time

hotspot

hotspot

knowledge